Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6607 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-03-04 (biospace.com)
New ALS Treatments Face Regulatory Uncertainty | BioSpace
Despite the approval of two novel therapies for this uniformly fatal neurodegenerative disease, experts say regulatory standards and expectations are still evolving.
Read more
2023-08-22 (nzz.ch)
Biotech: Biogen employees in Baar are worried about their job
The drug manufacturer Biogen is cutting more than every ninth job worldwide. Since functions within the headquarters are to disappear in advance, fear is raging at the international headquarters.
Read more
2023-06-07 (bioprocessintl.com)
Biogen latest to slam US gov over ‘draconian measures’ of IRA
Biogen’s CEO says the IRA is causing drugmakers uncertainty and could follow fellow biopharma Merck in suing the US government.
Read more